0000905718-15-000328.txt : 20150331 0000905718-15-000328.hdr.sgml : 20150331 20150331074028 ACCESSION NUMBER: 0000905718-15-000328 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150331 DATE AS OF CHANGE: 20150331 EFFECTIVENESS DATE: 20150331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scilex Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001603542 IRS NUMBER: 800861274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-236960 FILM NUMBER: 15736433 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DR. STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 949-413-2672 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DR. STREET 2: SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Scilex Pharmaceuticals, Inc DATE OF NAME CHANGE: 20140325 D 1 primary_doc.xml X0707 D LIVE 0001603542 Scilex Pharmaceuticals Inc. 101 LINDENWOOD DR. SUITE 225 MALVERN PA PENNSYLVANIA 19355 949-413-2672 DELAWARE None Scilex Pharmaceuticals, Inc Corporation true 2012 William Pedranti 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Anthony P. Mack 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Eric Floyd 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Jerrold B. Sendrow 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b false 2015-03-26 false true true false 0 Paulson Investment Company, LLC 5670 None None 1001 SE 5TH AVENUE #1460 PORTLAND OR OREGON 97204 CT CONNECTICUT OR OREGON TX TEXAS false 2025274 2025274 0 false 3 288285 true 0 0 true Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3. false Scilex Pharmaceuticals Inc. /s/ Anthony Mack Anthony Mack Chief Executive Officer and President 2015-03-31